Lipo-C without B-vitamins dosing — the clinic MIC injection context

"How much plain MIC" has no evidence-based answer, because the question has two missing pieces: MIC blends are compounded to different recipes at different pharmacies, and no dose-finding or efficacy study of any lipotropic injection has ever been published. In practice, clinics administer it as a roughly weekly intramuscular shot whose contents are set by their compounding pharmacy — which makes the schedule a business convention, not a pharmacological one.

Where these injections are offered, the commonly described pattern is:

• A single intramuscular injection, most often about once a week, though program schedules vary in both directions.
• Volumes typically in the 1–2 mL range, with the actual milligrams of methionine, inositol, and choline determined by the clinic's compounded formula — figures do not transfer between clinics.
• Positioning as an adjunct to a supervised diet and exercise program.

Because the product is not standardized, no fixed milligram schedule can be stated as authoritative.

It helps to see what the numbers would have to be anchored to. The choline literature — the strongest science in the blend — defines dietary adequate intakes (425 mg/day for adult women, 550 mg/day for adult men) set to prevent deficiency signs such as fatty liver (Zeisel & da Costa, Nutr Rev 2009). Those are eating targets, not injection doses, and they aim at deficiency prevention, not fat loss. No study has established what injected amount of any MIC component does anything for weight — so there is no correct number for a clinic to converge on, which is exactly why their numbers vary.

The same logic applies to the omitted ingredient: injectable B12 dosing exists as real medicine, but only in deficiency treatment (O'Leary & Samman, Nutrients 2010). This variant drops that component, so not even borrowed deficiency-medicine numbers apply to it.

Plain MIC blends are given as intramuscular (sometimes subcutaneous) injections by clinic staff, commonly into the deltoid, thigh, or gluteal muscle. They are clinic-administered — prepared by a compounding pharmacy, injected on-site — not a self-injection product. Without B12, the solution lacks the characteristic red color of the B-vitamin version, which is the quickest visual way to tell the two variants apart.

This is not an FDA-approved therapy, and the evidence for a weight-loss benefit at any dose is absent. The useful clinician conversation is not about milliliters but about whether the injection contributes anything to the program around it — and what evidence-based options (dietary choline is abundant in eggs, meat, and fish; approved weight-loss medications exist for appropriate candidates) would serve the same goal better. Reproducing clinic numbers outside a clinical setting keeps all of the uncertainty and removes the only oversight the practice has. For the evidence walkthrough, see the research and evidence page.